CFCThe Compounder Score
BSX logo

BSX — Boston Scientific Corporation

Medical DevicesHealthcare

$44.34

+$0.14 (+0.32%)

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular.

Market Cap

$64.27B

Forward P/E

14.2x

52-Week Range

$41.58$101.76

BSX Price History

Current price

$44.34

BSX return (1Y)

-57.8%

S&P 500 return (1Y)

+12.2%

vs S&P 500

-70.0 pts

Revenue vs. Net Income

$20.1B

Revenue · FY2025

Annual. Net margin is shown under each year.

RevenueNet income (green profit, red loss)

Free Cash Flow

$3.4B

FCF · FY2025

Annual. FCF margin is shown under each year.

Return on Capital Employed (ROCE)

9.8%

ROCE · FY2025

Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.

Total Assets vs. Total Liabilities

2.2x

Assets ÷ liabilities · FY2025

Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.

Total assetsTotal liabilities

CapEx as % of Revenue

5.6%

CapEx · FY2025

Annual. Green at or under the 5% maximum target, red above it.

Shares Outstanding

+0.6%

Dilution · FY2025

Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).